In 1998 a network of 20 regional tuberculosis (TB) laboratories (the Italian Multicentre Study on Resistance to Antituberculosis drugs (SMIRA) network) was established in Italy to implement proficiency testing and to monitor the prevalence of drug resistance nationwide. The network managed 30% of all TB cases reported in Italy each year. The aim of the present report is to describe: 1) the accuracy of drug-susceptibility testing in the network; 2) the prevalence of drug resistance for the period 1998-2000. Data were collected from the network laboratories. Sensitivity to streptomycin and ethambutol increased from the first survey (1998-1999) to the second survey (2000) from 87.7 to 91.9%. Specificity, predictive values for resistance and susceptibility, efficiency and reproducibility were consistent in both surveys. In previously untreated cases, the prevalence of multidrug-resistance was the same in both surveys (1.2%), while a slight decrease from the first to the second survey was observed for monoresistance to rifampicin (from 0.8 to 0.4%) and isoniazid (from 2.9 to 2%,). The significant association found between isoniazid resistance and immigration is a useful indicator for both clinicians managing individual tuberculosis cases and public health services planning control strategies.

Monitoring the quality of laboraties and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000 / G. Migliori, R. Centis, L. Fattorini, G. Besozzi, C. Saltini, G. Orefici, C. Piersimoni, A. Gori, A. Cassone, A. De Santis, V. Giorgio, P. Vinciguerra, G. Angarano, L. Petrozzi, D. Costa, F. Gozzellino, A. Perboni, D. Marchetti, M. Moro, A. Pascali, F. Falcone, V. Mariano, F. Rizza, P. Pretto, F. Turano, A. Matteelli, G. Carosi, S. Tedoldi, G. Pinsi, A. Farris, B. Farris, A. Spanevello, C. Foschi, G. Trucco, S. Aiolfi, T. Ceruti, M. Parpanesi, S. Calabro, G. Felisatti, E. Tortoli, F. Nutini, G. Montini, F. Fiorentini, V. D'Ambrosio, A. Ceraminiello, S. Bernorio, L. Buono, P. Montesano, E. Vinci, E. Sabato, S. Gamba, L. Codecasa, F. Mandler, V. Penati, P. Vaccarino, G. Bertoli, F. Rupianesi, M. Losi, L. Richeldi, G. Ferrara, E. Minuccio, G. Napolitano, G. Molinari, L. Saini, G. Garzone, C. Vertuccio, S. Marcias, M. Menozzi, P. Marone, V. Peona, C. Nascimbene, A. Pasi, A. Cascina, L. Casali, A. Monaco, S. Pauluzzi, O. Penza, M. Pasticci, F. Bistoni, T. Sposini, V. Colorizio, P. Bottrighi, A. Orsi, L. Schiavi, G. Macor, G. Moretti, R. Fatigante, A. Barbaro, G. Agati, F. Zaccara, S. Viola, R. Le Donne, G. Farinelli, D. Mancini, M. Ermeti, G. Orefici, E. Iona, M. Tronci, A. Bisetti. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 21:1(2003), pp. 129-134. [10.1183/09031936.03.00047402]

Monitoring the quality of laboraties and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000

A. Gori;
2003

Abstract

In 1998 a network of 20 regional tuberculosis (TB) laboratories (the Italian Multicentre Study on Resistance to Antituberculosis drugs (SMIRA) network) was established in Italy to implement proficiency testing and to monitor the prevalence of drug resistance nationwide. The network managed 30% of all TB cases reported in Italy each year. The aim of the present report is to describe: 1) the accuracy of drug-susceptibility testing in the network; 2) the prevalence of drug resistance for the period 1998-2000. Data were collected from the network laboratories. Sensitivity to streptomycin and ethambutol increased from the first survey (1998-1999) to the second survey (2000) from 87.7 to 91.9%. Specificity, predictive values for resistance and susceptibility, efficiency and reproducibility were consistent in both surveys. In previously untreated cases, the prevalence of multidrug-resistance was the same in both surveys (1.2%), while a slight decrease from the first to the second survey was observed for monoresistance to rifampicin (from 0.8 to 0.4%) and isoniazid (from 2.9 to 2%,). The significant association found between isoniazid resistance and immigration is a useful indicator for both clinicians managing individual tuberculosis cases and public health services planning control strategies.
Settore MED/17 - Malattie Infettive
Article (author)
File in questo prodotto:
File Dimensione Formato  
129.full.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 78.27 kB
Formato Adobe PDF
78.27 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/629227
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 14
  • ???jsp.display-item.citation.isi??? ND
social impact